Used as a chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structural features enable selective binding in biological systems, making it valuable in drug discovery for oncology and inflammatory diseases. The oxazole ring and bromopyridine moiety allow for further functionalization through cross-coupling reactions, facilitating the creation of compound libraries for screening. Its stereochemistry plays a critical role in enhancing potency and selectivity in target molecules.